Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80071412

Market status:

Marketed

Licence Status:

Active

Brand name(s):

M-K20 Soluble

Licence holder:

Mantra Pharma Inc.

Dosage Form:

Tablet, film coated, extended release

Recommended route of administration:

Oral

Recommended use or purpose:

Treatment or prevention of hypokalemia (potassium depletion) which does not result from dietary deficiency.

Risk Information:

Cautions and Warnings 

To be taken only on the advice of a physician. Discontinue use and consult a health care practitioner immediately if you experience numbness of the extremities, muscle weakness, paralysis, cardiac arrhythmias, low blood pressure, or confusion. A probable association exists between the use of coated tablets containing potassium salts, with or without thiazide diuretics, and the incidence of serious small bowel ulceration. Such preparations should be used only when adequate dietary supplementation is not practical, and should be discontinued if abdominal pain, distention, nausea, vomiting or gastrointestinal bleeding occur. May cause nausea, vomiting, diarrhea, abdominal cramps; discontinue use and consult a health care practitioner if these symptoms are severe. If you have a kidney or heart condition, consult a health care practitioner prior to use. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. The use of potassium supplements with potassium sparing diuretics (spironolactone, triamterene, amiloride) may lead to hyperkalemia. Prescribing information is available to physicians and pharmacists on request. Where impaired renal function exists, the use of potassium supplements must be monitored closely.

Contra-Indications 

If you have adrenal insufficiency or uncontrolled diabetes mellitus, do not use. If you are taking any prescription medications especially those which increase serum potassium such as potassium-sparing diuretics or angiotensin converting enzyme (ACE) inhibitors, do not use. Not to be used following vigorous exercise or acute dehydration (unless administered with an appropriate balance of other mineral salts, e.g. sodium). Do not use with other potassium-containing supplements or with potassium-containing salt-substitutes. If you have a gastrointestinal ulceration or obstruction, do not use. Do not use if you have trouble swallowing or if you are at high risk for potassium chloride induced gastric lesions.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Potassium	20.0 mEq 780.0 milligrams

List of non-medicinal ingredients:

• Croscarmellose sodium
• Ethylcellulose
• Microcrystalline cellulose

Date of licensing:

2016-07-26

Revised date of licence:

2016-08-09